RG
MRSN icon

Redmile Group’s Mersana Therapeutics MRSN Stock Holding History

Redmile Group’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-67,945
Closed -$5.59M – 73
2023
Q2 		$5.59M Buy
+67,945
New +$5.59M 0.21% 57